tirzepatide for rheumatoid arthritis Mounjaro and Arthritis: What You Need to Know Glucagon-like peptide-1 receptor agonists in

FDA NDA filed December 2025

Once the platform was located the animal was allowed a 30 second rest period before the next trial started

The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study

Further zooming into the impacts of GLP-1 on food consumption, a Morgan Stanley Research report provides interesting early insights on how GLP-1 users eating habits are changing (see figure below)

Real-world data since 2021 has confirmed these trial findings, with consistency across different healthcare settings and patient populations